Xinyu Wu

机构：North Sichuan Medical University · ORCID：0000-0002-9094-9951

发表论文 39 篇 · 总被引 440 次 · h-index 13

代表论文

• A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID (2025 · Nature Communications · 被引 37)
• Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19 (2024 · Nature Communications · 被引 34)
• Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape (2024 · Nature Communications · 被引 22)
• Tetrahydropalmatine promotes random skin flap survival in rats via the PI3K/AKT signaling pathway (2024 · Journal of Ethnopharmacology · 被引 21)
• Luteolin Mitigates Photoaging Caused by UVA-Induced Fibroblast Senescence by Modulating Oxidative Stress Pathways (2025 · International Journal of Molecular Sciences · 被引 17)
• Silybin mitigated liver and brain damage after difenoconazole exposure: Crosstalk between oxidative stress, inflammation, ferroptosis and apoptosis (2024 · Pesticide Biochemistry and Physiology · 被引 17)